Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

ETR/PHGN stock hub

ETR/PHGN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/PHGNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

779M

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/PHGN

In the news

Latest news · ETR/PHGN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.5

P25 n/aP50 n/aP75 n/a

Trailing P/E72.7

P25 n/aP50 n/aP75 n/a

ROE5

P25 n/aP50 n/aP75 n/a

ROIC10

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/PHGN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Netherlands
Country code	DE
Employees	407
Employees Change	22%
Employees Change Percent	5.76
Enterprise value	EUR 732.2M
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 779M
Price	EUR 1.41
Price currency	EUR
Rev Per Employee	787,361.36x
Sic	2836
Symbol	etr/PHGN
Website	https://www.pharming.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.38%
EV Earnings	68.32x
EV/EBIT	23.86x
EV/EBITDA	19.74x
EV/FCF	15.15x
EV/Sales	2.28x
FCF yield	6.2%
Forward P/E	19.47x
P/B ratio	3.34x
P/E ratio	72.69x
P/S ratio	2.43x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.44%
EBITDA Margin	11.44%
FCF margin	15.08%
Gross margin	88.14%
Gross Profit	EUR 282.5M
Gross Profit Growth	14.12%
Gross Profit Growth Q	-7.02%
Gross Profit Growth3 Y	20.79%
Gross Profit Growth5 Y	12.61%
Net Income	EUR 10.7M
Net Income Growth5 Y	-19.76%
Pretax Margin	5.38%
Profit Margin	3.34%
Profit Per Employee	EUR 26,332
ROA	4.89
Roa5y	1.24
ROCE	9.25
ROE	5.04
Roe5y	1.21
ROIC	10
Roic5y	1.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth5 Y	-22.02
FCF Growth	994.32%
FCF Growth5 Y	-2.9%
OCF Growth	827.48%
OCF Growth Q	741.38%
OCF Growth5 Y	-4.37%
Revenue Growth	15.21x
Revenue Growth Q	-8.4x
Revenue Growth3 Y	22.39x
Revenue Growth5 Y	12.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.83
Assets	EUR 424.4M
Cash	EUR 147.6M
Current Assets	EUR 250.6M
Current Liabilities	EUR 95.3M
Debt	EUR 100.8M
Debt EBITDA	EUR 2.75
Debt Equity	EUR 0.43
Debt FCF	EUR 2.09
Equity	EUR 233.3M
Interest Coverage	3.25
Liabilities	EUR 191.2M
Long Term Assets	EUR 173.8M
Long Term Liabilities	EUR 95.9M
Net Cash	EUR 46.8M
Net Cash By Market Cap	EUR 6.01
Net Debt EBITDA	EUR -1.28
Net Debt Equity	EUR -0.2
Net Debt FCF	EUR -0.97
Tangible Book Value	EUR 119.7M
Tangible Book Value Per Share	EUR 0.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.63
Inventory Turnover	0.71
Net Working Capital	EUR 18.3M
Quick ratio	2.05
Working Capital	EUR 158.9M
Working Capital Turnover	EUR 2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-13.48%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	1.4
All Time High	1.78
All Time High Change	-20.9%
All Time High Date	2026-01-27
All Time Low	1.1
All Time Low Change	27.65%
All Time Low Date	2025-11-05
ATR	0.04
Ch YTD	-1.54
High	1.41
High52	1.78
High52 Date	2026-01-27
High52ch	-20.9%
Low	1.4
Low52	1.1
Low52 Date	2025-11-05
Low52ch	37.37%
Ma50ch	0.28%
RSI	48.17
RSI Monthly	0
RSI Weekly	55.49
Sharpe ratio	0.59x
Sortino ratio	0.98
Total Return	-13.48%
Tr YTD	-1.54
Tr1m	-2.29%
Tr1w	0.21%
Tr3m	1.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 30.3M
Operating Income Growth	158.9
Operating Income Growth5 Y	-10.75
Operating margin	9.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	695,284,727%
Net Borrowing	-13,995,612.8
Shares Insiders	1.55%
Shares Institutions	22.84%
Shares Qo Q	-1.64%
Shares Yo Y	13.48%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 35.8M
Average Volume	4,632.25x
Bv Per Share	0.31
CAPEX	EUR -611,447
Ch1m	-2.29
Ch1w	0.21
Ch3m	1.22
Ch6m	27.42
Change	0.5%
Change From Open	0.57
Close	1.4
Days Gap	-0.07
Depreciation Amortization	6,268,983.1
Dollar Volume	2,154.2
Earnings Date	2026-05-07
EBIT	EUR 30.3M
EBITDA	EUR 36.7M
EPS	EUR 0.01
F Score	5
FCF	EUR 48.3M
FCF EV Yield	6.6x
Financing CF	-874,238
Fiscal Year End	December
Founded	1,988
Graham Number	0.42868
Graham Upside	-69.55
Income Tax	EUR 6.7M
Investing CF	-59,148,993
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	EUR 0.1
Lynch Upside	-93.12
Ma20	1.45
Ma20ch	-2.56%
Net CF	-6,690,352
Next Earnings Date	2026-07-30
Open	1.4
P FCF Ratio	16.12
P OCF Ratio	15.92
Position In Range	100
Ppne	19,586,226.3
Price Date	2026-05-06
Price EBITDA	EUR 21.24
Ptbv Ratio	6.51
Relative Volume	0.33x
Revenue	320,456,075x
SBC By Revenue	3.9x
Share Based Comp	12,502,130
Tax By Revenue	2.08x
Tax Rate	38.57%
Tr6m	27.42%
Volume	1,530

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ETR/PHGN pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns ETR/PHGN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+22.8%

Share of float held by funds and institutions

Insider ownership

+1.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+13.5%

Negative means the company is buying back shares.

Technical

ETR/PHGN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.2

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.59

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/PHGN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/PHGN stock rating?

etr/PHGN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/PHGN analysis?

The full report lives at /stocks/etr/PHGN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/PHGN?

The latest report frames etr/PHGN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/PHGN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.